Search

everythinglearnresearchcommunity

for

Search:↓

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Cyproterone acetate-estrogen most effective for hirsutism, but consider side effects and patient needs.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Young Czech women with PCOS have a higher risk of heart problems and should be regularly checked for cholesterol and glucose issues.

The document concludes with guidance for doctors on diagnosing and treating hirsutism effectively and safely.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Reproductive factors can increase hypertension risk and affect cardiovascular health.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

South Asian women with PCOS present with different symptoms compared to White women, influenced by ethnicity, obesity, and age.

Mutations in certain receptors can cause diseases and offer new treatment options.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Testosterone affects brain functions and contributes to sex differences, influencing conditions like autism.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

All treatments reduce hair growth; low dose flutamide most effective with fewer side effects.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.